PTJ
HZNP

Paul Tudor Jones’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Paul Tudor Jones’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,700
Closed -$278K – 3025
2023
Q2 		$278K Buy
+2,700
New +$285K ﹤0.01% 2046

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Paul Tudor Jones's HZNP Position: Q4 2023 in Review

Paul Tudor Jones sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 1,303,844 shares — an estimated $151M sold.

Paul Tudor Jones first reported a position in HZNP in Q4 2013 and held it in 28 quarters. The position peaked at $151M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Paul Tudor Jones reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Paul Tudor Jones sold 1,303,844 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $151M.
  • Paul Tudor Jones first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2013 and held it in 28 quarters.
  • Paul Tudor Jones's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $151M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Tudor Investment Corp's 13F filing for Q4 2023, filed 14 Feb 2024.